Page 17 - RxExam's Naplex Theory Book Part 2
P. 17

www.pharmacyexam.com                                                                   Krisman


                                Dose               Special Notes

                Allopurinol                        6). Allopurinol (Zyloprim) inhibits the enzymatic oxidation of
                (Tablet)                           Mercaptopurine and Azathioprine, the sulfur-containing analogue of
                (Injection)                        hypoxanthine, to 6-thiouric acid. This oxidation, which is catalyzed by
                                                   xanthine oxidase, inactivates Mercaptopurine. Hence, the inhibition of
                                                   such oxidation by Allopurinol (Zyloprim) may result in as much as a
                                                   75% reduction in the therapeutic dose requirement of Mercaptopurine
                                                   when the two compounds are given together.

                                                   7). The most frequent adverse reaction to Allopurinol (Zyloprim) is skin
                                                   rash. Skin reactions can be severe and sometimes fatal. Therefore,
                                                   treatment with Allopurinol (Zyloprim) should be discontinued
                                                   immediately if a rash develops. Some patients with the most severe
                                                   reaction also had fever, chills, arthralgias, cholestatic jaundice,
                                                   eosinophilia and mild leukocytosis or leukopenia.

                Febuxostat      1. Hyperuricemia:   1). Febuxostat (Uloric) is a xanthine oxidase (XO) inhibitor, the enzyme
                (Tablet)                           responsible for the conversion of hypoxanthine to xanthine and of
                                40 to 80 mg once   xanthine to uric acid, the end product of purine metabolism in human.
                                daily without
                                regard to food or   2). Febuxostat (Uloric) is indicated for the chronic management of
                                antacids.          hyperuricemia in patients with gout. It is NOT recommended for the
                                                   treatment of asymptomatic hyperuricemia.

                                                   3). Gout flares may occur after initiation of Febuxostat (Uloric) due to
                                                   changing serum uric acid levels resulting in mobilization of urate from
                                                   tissue deposits. Flare prophylaxis with a non-steroidal anti-
                                                   inflammatory drug (NSAID) or Colchicine is recommended upon
                                                   initiation of Febuxostat (Uloric). If a gout flare occurs during
                                                   Febuxostat (Uloric) treatment, Febuxostat (Uloric) need not be
                                                   discontinued.

                                                   4). Inhibition of xanthine oxidase (XO) enzyme may cause increased
                                                   plasma concentrations and toxicities of Mercaptopurine, Azathioprine
                                                   and Theophylline. Concurrent use should be strictly avoided.

                                                   5). Liver function abnormalities, nausea, arthralgia and rash are
                                                   commonly reported side effects of Febuxostat (Uloric).

                B). Uric Acid Specific Enzyme

                Pegloticase     1. Gout:           1). Pegloticase (Krystexxa) is a uric acid specific enzyme which is a
                (Injection)     8 mg via slow (120  recombinant uricase and achieves its therapeutic effect by catalyzing
                                minutes) IV infusion   the oxidation of uric acid to allantoin, thereby lowering serum uric
                                every 2 weeks.     acid. Allantoin is an inert and water soluble purine metabolite. It is
                                                   readily eliminated, primarily by renal excretion.


                                                             16
   12   13   14   15   16   17   18   19   20   21   22